Crumly & Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Crumly & Associates's PFE Position: Q2 2025 in Review
Crumly & Associates sold out of Pfizer (PFE) in Q2 2025, closing a stake of 16,111 shares — an estimated $408K sold.
Crumly & Associates first reported a position in PFE in Q3 2020 and held it in 19 quarters. The position peaked at $1.06M in Q2 2022. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Crumly & Associates reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Crumly & Associates sold 16,111 Pfizer shares in Q2 2025, an estimated $408K.
- Crumly & Associates first reported a position in Pfizer in Q3 2020 and held it in 19 quarters.
- Crumly & Associates's Pfizer position peaked at $1.06M in Q2 2022.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Crumly & Associates's 13F filing for Q2 2025, filed 2 Jul 2025.